Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997299968> ?p ?o ?g. }
- W1997299968 endingPage "1896" @default.
- W1997299968 startingPage "1890" @default.
- W1997299968 abstract "The safety and immunogenicity of a replication deficient adenovirus serotype 35 tuberculosis (TB) vaccine containing gene inserts for Antigens (Ag) 85A, Ag85B and TB10.4 (AERAS-402/AD35.TB-S) was evaluated in previously BCG vaccinated, HIV-infected South African adults with baseline CD4 counts >350 cells/mm(3).Subjects were randomized (1:1) to receive two doses of either intramuscular AERAS-402/AD35.TB-S or placebo at month 0 and at month 1. Participants were monitored for adverse events 28 days after each vaccination and for serious adverse events over 12 months. CD4(+) and CD8(+) T-cell and antibody responses to vaccine antigens were evaluated post first and second vaccination.26 subjects were randomly assigned to receive AERAS-402/AD35.TB-S (N=13) or placebo (N=13). The mean age was 29.0 years, all were Black-African, 88.5% were female, 46.2% were QuantiFERON Test (QFT) positive at baseline, and the median CD4 count was 559.5 cells/mm(3), all similar by treatment group. All subjects received their first vaccination and 24 subjects received their second vaccination. Injection site reactions and some systemic reactions were reported more commonly in the AERAS-402/AD35.TB-S versus placebo recipients. AERAS-402/AD35.TB-S did not appear to influence CD4 counts and HIV-1 viral load over the course of study follow-up. AERAS-402/AD35.TB-S induced a mixed CD4(+) T-cell and CD8(+) T-cell responses to Ag85B. The CD4(+) T-cell responses peaked to Ag85A and Ag85B 14 days after the second vaccination and had declined by Day 182. AERAS-402/AD35.TB-S predominantly induced CD4(+) T-cells expressing three (IFN-γ, TNF, IL-2) or two (IL-2 and TNF) cytokines, two weeks after the last vaccination, which did not differ by baseline Quantiferon test status. AERAS-402/AD35.TB-S induced strong Ag85A and Ag85B specific antibody responses, particularly after the second vaccination.AERAS-402/AD35.TB-S was well tolerated, safe and induced predominantly polyfunctional CD4(+) and CD8(+) T-cell responses to vaccine." @default.
- W1997299968 created "2016-06-24" @default.
- W1997299968 creator A5023641203 @default.
- W1997299968 creator A5025743822 @default.
- W1997299968 creator A5027350232 @default.
- W1997299968 creator A5040347621 @default.
- W1997299968 creator A5043150960 @default.
- W1997299968 creator A5060261035 @default.
- W1997299968 creator A5072617088 @default.
- W1997299968 creator A5075423530 @default.
- W1997299968 creator A5084393283 @default.
- W1997299968 date "2015-04-01" @default.
- W1997299968 modified "2023-10-17" @default.
- W1997299968 title "The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3" @default.
- W1997299968 cites W1965443156 @default.
- W1997299968 cites W1971656628 @default.
- W1997299968 cites W1983042663 @default.
- W1997299968 cites W1984899749 @default.
- W1997299968 cites W1984979380 @default.
- W1997299968 cites W1998169449 @default.
- W1997299968 cites W2002319260 @default.
- W1997299968 cites W2004240693 @default.
- W1997299968 cites W2026464965 @default.
- W1997299968 cites W2040780498 @default.
- W1997299968 cites W2046730970 @default.
- W1997299968 cites W2059505459 @default.
- W1997299968 cites W2061773693 @default.
- W1997299968 cites W2065461284 @default.
- W1997299968 cites W2086707243 @default.
- W1997299968 cites W2103734560 @default.
- W1997299968 cites W2143749967 @default.
- W1997299968 cites W2165171138 @default.
- W1997299968 cites W2325369408 @default.
- W1997299968 doi "https://doi.org/10.1016/j.vaccine.2015.02.004" @default.
- W1997299968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25698492" @default.
- W1997299968 hasPublicationYear "2015" @default.
- W1997299968 type Work @default.
- W1997299968 sameAs 1997299968 @default.
- W1997299968 citedByCount "32" @default.
- W1997299968 countsByYear W19972999682015 @default.
- W1997299968 countsByYear W19972999682016 @default.
- W1997299968 countsByYear W19972999682017 @default.
- W1997299968 countsByYear W19972999682018 @default.
- W1997299968 countsByYear W19972999682019 @default.
- W1997299968 countsByYear W19972999682020 @default.
- W1997299968 countsByYear W19972999682021 @default.
- W1997299968 countsByYear W19972999682022 @default.
- W1997299968 countsByYear W19972999682023 @default.
- W1997299968 crossrefType "journal-article" @default.
- W1997299968 hasAuthorship W1997299968A5023641203 @default.
- W1997299968 hasAuthorship W1997299968A5025743822 @default.
- W1997299968 hasAuthorship W1997299968A5027350232 @default.
- W1997299968 hasAuthorship W1997299968A5040347621 @default.
- W1997299968 hasAuthorship W1997299968A5043150960 @default.
- W1997299968 hasAuthorship W1997299968A5060261035 @default.
- W1997299968 hasAuthorship W1997299968A5072617088 @default.
- W1997299968 hasAuthorship W1997299968A5075423530 @default.
- W1997299968 hasAuthorship W1997299968A5084393283 @default.
- W1997299968 hasConcept C126322002 @default.
- W1997299968 hasConcept C142724271 @default.
- W1997299968 hasConcept C147483822 @default.
- W1997299968 hasConcept C159047783 @default.
- W1997299968 hasConcept C167672396 @default.
- W1997299968 hasConcept C197934379 @default.
- W1997299968 hasConcept C203014093 @default.
- W1997299968 hasConcept C204787440 @default.
- W1997299968 hasConcept C22070199 @default.
- W1997299968 hasConcept C27081682 @default.
- W1997299968 hasConcept C2776090121 @default.
- W1997299968 hasConcept C2776763545 @default.
- W1997299968 hasConcept C2777975735 @default.
- W1997299968 hasConcept C2779806340 @default.
- W1997299968 hasConcept C2780868878 @default.
- W1997299968 hasConcept C2781069245 @default.
- W1997299968 hasConcept C71924100 @default.
- W1997299968 hasConcept C8891405 @default.
- W1997299968 hasConceptScore W1997299968C126322002 @default.
- W1997299968 hasConceptScore W1997299968C142724271 @default.
- W1997299968 hasConceptScore W1997299968C147483822 @default.
- W1997299968 hasConceptScore W1997299968C159047783 @default.
- W1997299968 hasConceptScore W1997299968C167672396 @default.
- W1997299968 hasConceptScore W1997299968C197934379 @default.
- W1997299968 hasConceptScore W1997299968C203014093 @default.
- W1997299968 hasConceptScore W1997299968C204787440 @default.
- W1997299968 hasConceptScore W1997299968C22070199 @default.
- W1997299968 hasConceptScore W1997299968C27081682 @default.
- W1997299968 hasConceptScore W1997299968C2776090121 @default.
- W1997299968 hasConceptScore W1997299968C2776763545 @default.
- W1997299968 hasConceptScore W1997299968C2777975735 @default.
- W1997299968 hasConceptScore W1997299968C2779806340 @default.
- W1997299968 hasConceptScore W1997299968C2780868878 @default.
- W1997299968 hasConceptScore W1997299968C2781069245 @default.
- W1997299968 hasConceptScore W1997299968C71924100 @default.
- W1997299968 hasConceptScore W1997299968C8891405 @default.
- W1997299968 hasFunder F4320311178 @default.
- W1997299968 hasIssue "15" @default.
- W1997299968 hasLocation W19972999681 @default.
- W1997299968 hasLocation W19972999682 @default.